Ticker Details
BioAge Labs, Inc.
IPO Date:	September 26, 2024
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$738.36M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 3.41%
Avg Daily Range (30 D):	$0.61 | 3.49%
Avg Daily Range (90 D):	$0.68 | 3.61%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	.33M
Avg Daily Volume (90 D):	.49M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	191
Avg Institutional Trade:	$1.39M
Avg Institutional Trade (30 D):	$.85M
Avg Institutional Trade (90 D):	$1.25M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.31M
Avg Closing Trade (30 D):	$.78M
Avg Closing Trade (90 D):	$1.17M
Avg Closing Volume:	100.29K

News

May 22, 2026 @ 1:00 PM BioAge Labs to Present at Upcoming Investor Confer... Source: Na

May 20, 2026 @ 1:50 PM Cell-Based Therapies Poised to Disrupt Multi-Billi... Source: Market News Updates

Apr 21, 2026 @ 11:00 AM BioAge Reports Positive Phase 1 Data for BGE-102, ... Source: Bioage Labs, Inc.

Jan 22, 2026 @ 3:30 AM BioAge Announces Pricing of Upsized $115.0 Million... Source: Not Specified

Jan 20, 2026 @ 9:01 PM BioAge Announces Proposed Public Offering Source: Globe Newswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.4	$-.52	$-.72
Diluted EPS	$-2.4	$-.52	$-.72
Revenue	$10.32M	$2.77M	$3.08M
Gross Profit
Net Income / Loss	$-89.93M	$-22.25M	$-25.94M
Operating Income / Loss	$-101.71M	$-25.38M	$-28.42M
Cost of Revenue
Net Cash Flow	$-15.61M	$52.92M	$-26.67M
PE Ratio